![Victoria Niklas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Victoria Niklas
Director/Board Member at FIBROBIOLOGICS, INC.
Net worth: 91 350 $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Peter O'Heeron | M | 61 | 3 years | |
Josh Distler | M | 48 |
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | - |
Matthew Link | M | 49 | 3 years | |
Richard C. Cilento | M | 61 | 3 years | |
Mark McHale | M | 59 |
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 years |
Stacy Coen | F | 53 | 3 years | |
Robert Hoffman | M | 58 | 3 years | |
Mark Andersen | M | 53 | 2 years | |
Tauhid Ali | M | 56 |
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 years |
Mark Hannon | M | - |
Prolacta Bioscience, Inc.
![]() Prolacta Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Prolacta Bioscience, Inc. provides specialty formulations of human milk for the nutritional needs of premature and critically ill infants. Its products include Prolact+ H2MF, Prolact+4, Prolact+6, Prolact+8, Prolact+10 and Neo20. The company was founded by Elena Taggart Medo in1999 and is headquartered in Duarte, CA. | 8 years |
Marie Yurkovich | M | - |
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | - |
Edwin Moses | M | 69 |
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 years |
John Mazziotta | M | - |
UCLA Health Systems
![]() UCLA Health Systems Hospital/Nursing ManagementHealth Services UCLA Health Systems operates hospitals. The private company is based in Los Angeles, CA and has subsidiaries in United States. The company was founded in 1955 by Benjamin J. Ansell. John Mazziotta has been the CEO of the company since 2015. | 9 years |
Daniel Curran | M | 57 |
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 years |
Johnese Spisso | F | 63 |
UCLA Health Systems
![]() UCLA Health Systems Hospital/Nursing ManagementHealth Services UCLA Health Systems operates hospitals. The private company is based in Los Angeles, CA and has subsidiaries in United States. The company was founded in 1955 by Benjamin J. Ansell. John Mazziotta has been the CEO of the company since 2015. | 8 years |
David Colpman | M | 62 |
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 years |
Ramy Farid | M | 59 |
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 years |
Hamid Khoja | M | 55 | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David Feinberg | M | 61 |
UCLA Health Systems
![]() UCLA Health Systems Hospital/Nursing ManagementHealth Services UCLA Health Systems operates hospitals. The private company is based in Los Angeles, CA and has subsidiaries in United States. The company was founded in 1955 by Benjamin J. Ansell. John Mazziotta has been the CEO of the company since 2015. | - |
David C. Dreyer | M | 67 |
Prolacta Bioscience, Inc.
![]() Prolacta Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Prolacta Bioscience, Inc. provides specialty formulations of human milk for the nutritional needs of premature and critically ill infants. Its products include Prolact+ H2MF, Prolact+4, Prolact+6, Prolact+8, Prolact+10 and Neo20. The company was founded by Elena Taggart Medo in1999 and is headquartered in Duarte, CA. | - |
Molly Joel Coye | M | 76 |
UCLA Health Systems
![]() UCLA Health Systems Hospital/Nursing ManagementHealth Services UCLA Health Systems operates hospitals. The private company is based in Los Angeles, CA and has subsidiaries in United States. The company was founded in 1955 by Benjamin J. Ansell. John Mazziotta has been the CEO of the company since 2015. | 5 years |
Virginia Mcferran | F | 60 |
UCLA Health Systems
![]() UCLA Health Systems Hospital/Nursing ManagementHealth Services UCLA Health Systems operates hospitals. The private company is based in Los Angeles, CA and has subsidiaries in United States. The company was founded in 1955 by Benjamin J. Ansell. John Mazziotta has been the CEO of the company since 2015. | 5 years |
Marti Arvin | F | - |
UCLA Health Systems
![]() UCLA Health Systems Hospital/Nursing ManagementHealth Services UCLA Health Systems operates hospitals. The private company is based in Los Angeles, CA and has subsidiaries in United States. The company was founded in 1955 by Benjamin J. Ansell. John Mazziotta has been the CEO of the company since 2015. | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 15 | 65.22% |
United Kingdom | 8 | 34.78% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Victoria Niklas
- Personal Network